The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Breast Cancer Survivorship, Quality of Life, and Late Toxicities
Open accessAbstract
Breast cancer is the most frequent cancer in women: in 2018, almost two million cases have been diagnosed all over the world and it represents the principal cause of death from a neoplastic disease in women. In the past years, breast cancer prognosis has significantly improved over time: currently 5-year survival rates are in the range of 90%, and 10-year survival is about 80%. This improvement has been mostly observed in western countries, due to high coverage and compliance with screening programs, leading to early diagnosis, i.e., when the disease is at a subclinical level, and to an improvement in tumor molecular characterization and innovative systemic treatments. Yet the identification of different biological breast cancer subtypes prompted the development of innovative targeted agents and improved treatment personalization. On the other hand, longer survival rates and increasing proportions of cured patients require dedicated strategies to manage long-term sequelae of breast cancer treatments, with particular attention to quality of life. This review analyzes the most important issues, potentially occurring with cancer treatments, concerning long-term sequelae and quality of life, to define a global approach to breast cancer survivorship.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to somatic side effects of the therapy, such as neurotoxicity and cardiotoxicity, lymphoedema or pain [6–8], increased tumour-related stress or mental illnesses such as anxiety and depression play a central role in follow-up care.”
From The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Zamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,639
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L. D., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,456
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164
Baum, M., Budzar, A. U., Cuzick, J. M., Forbes, J., Houghton, J., Klijn, J. G. M., & Sahmoud, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09088-8 · Cited by 1,958
Zamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,800
Sledge, G. W., Toi, M., Neven, P., Sohn, J., Inoue, K., Pivot, X., Burdaeva, O., Okera, M., Masuda, N., Kaufman, P. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7585 · Cited by 1,680
Overall survival with ribociclib plus endocrine therapy in breast cancer
Im, S.-A., Lu, Y.-S., Bardia, A., Harbeck, N., Colleoni, M., Franke, F., Chow, L., Sohn, J., Lee, K.-S., Campos-Gomez, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903765 · Cited by 1,001
Piccart, M., Hortobagyi, G. N., Campone, M., Pritchard, K. I., Lebrun, F., Ito, Y., Noguchi, S., Perez, A., Rugo, H. S., Deleu, I., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu456 · Cited by 574
Cardiotoxicity of anticancer treatments
Ewer, M. S., & Ewer, S. M. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.65 · Cited by 436
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–330 of 330
Bayo-Calero, J. L., Cartagena, S. S. C., Jimenez-Ruiz, F. J., & Tarazona, V. A. (2026) · Journal of Integrative Medicine and Research · doi:10.4103/jimr.jimr_64_25
Soleimani, H., Alamdaran, S. A., Rad, M. P., Doostparast, A., Ghandhari, M., Nooghabi, A. J., & Zabolian, R. (2026) · Sonography · doi:10.1002/sono.70051
Self-efficacy in the managing late sequelae in long-term breast cancer survivors in Spain
Soto‐Ruiz, N., Escalada‐Hernández, P., Pimentel-Parra, G. A., Leite, A. C. A. B., de Murieta, A. B.-S., & García‐Vivar, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-43904-y
Andam, S. E., Tagoe, E. A., Aikins, A. R., & Quaye, O. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102556
Zhou, B., Cipurko, D., Dejenie, R., Zietowski, M. L., Wong, D. E., & Hanson, S. E. (2026) · Cancers · doi:10.3390/cancers18071052
Cao, Y., Lee, K., Yusuf, A., Chen, S. T., Dong, X., Li, L., & Lim, P. Y. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s568638
Paunescu, A., Préau, M., Delpierre, C., Pannard, M., & Kvaskoff, M. (2026) · Bulletin du Cancer · doi:10.1016/j.bulcan.2026.02.005
Zhou, X., Fan, Q., Zhu, D., Kang, J., & Lv, L. (2026) · Tumori Journal · doi:10.1177/03008916261434125
Assimilating breast cancer experience: a contrasting case study
Machado, R., Basto, I., Viana, B., Almeida, B., Barbosa, A., Pinhel, C., Pereira, L., Stiles, W. B., & Pinheiro, P. (2026) · Counselling Psychology Quarterly · doi:10.1080/09515070.2026.2659606
Colaes, R., Schroyen, G., Radwan, A. M., Laic, R. G., Sleurs, C., Helsper, S., Himmelreich, U., Hatse, S., Smeets, A., Deprez, S., et al. (2026) · Breast · doi:10.1016/j.breast.2026.104788
Ruggeri, S. Y., Lippincott, C. L. R., Alexander, G. L., Ellis, R. J. B., Chesnut, S. R., & Erickson, L. A. (2026) · Cancer Medicine · doi:10.1002/cam4.71925
Tsai, C.-S., Szewczyk, W., Lee, H., Drerup, M. L., Blakeney, E. A., Greenlee, H., Heffner, J. L., Vasbinder, A. L., & Reding, K. W. (2026) · JMIR Formative Research · doi:10.2196/85386
Duplancic, V., Bobinac, A., Vončina, L., Hraste, K., Vuger, A. T., Šeparović, R., & Vrdoljak, E. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04562-4
Sahi, M. A., Waqar, A. S., Siddique, A., Asif, J., Waqar, A., & Rasul, S. (2026) · Cureus · doi:10.7759/cureus.110274
Rognoni, C., Cavallaro, L., Grassi, G., Caumo, F., Depretto, C., Folli, S., Minelli, S., Pezzella, M., Rocco, N., Romeo, V., et al. (2026) · PharmacoEconomics - Open · doi:10.1007/s41669-026-00663-w
Duplancic, V., Bobinac, A., Vončina, L., Hraste, K., Vuger, A. T., Šeparović, R., & Vrdoljak, E. (2026) · Healthcare · doi:10.3390/healthcare14121693
Cid-Bassaletti, C., Salcines-Rueda, L., Gil-Hernández, S., & Crespo-Cobo, P. (2026) · Rehabilitation Oncology · doi:10.1097/01.reo.0000000000000416
Liang, J., & Tong, W. G. (2026) · Biomedical Optics Express · doi:10.1364/boe.604794
Tabbakhian, P., Mohajerin, B., Sabet, B., & Kianimoghadam, A. S. (2026) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_513_25
Bioinformatic design of optimized therapeutic peptides for targeted breast cancer therapy
Oladipo, E. K., Adegboye, O. O., Adeyemo, S. F., Akinboade, M. W., Iwalokun, B. A., Ajani, O. F., Ariyo, O. E., & Onyeaka, H. N. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-01009-3
The role of chimeric antigen receptor (CAR) T cell therapy in breast cancer
Farajzadeh, A., Mahmoudi, M., Yazdani, S., Barati, A. M., Kheder, R. K., Rostami, O., Fadaee, A., Raouf-Rahmati, A., & Esmaeili, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117280
Abbreviated MRI protocol in breast cancer diagnosis: comparison with the full diagnostic protocol
Si, J., Xu, Q., He, X., Shi, F., Yan, Y., Shu, J., Feng, Z., & Zhang, L. (2026) · Polish Journal of Radiology · doi:10.5114/pjr/222561
Design and usability of the CUMACA-M mobile app for long-term breast cancer survivors
Soto‐Ruiz, N., Escalada‐Hernández, P., de Murieta, A. B.-S., Leite, A. C. A. B., Pimentel-Parra, G. A., & García‐Vivar, C. (2026) · Health Policy and Technology · doi:10.1016/j.hlpt.2026.101313
Douglas, A., Moore, T. M., Hughes, G. K., Bacani, R. C., Szymanski, D. B., Moody, M., Syed, D. F., & Vassar, M. (2026) · Clinical Breast Cancer · doi:10.1016/j.clbc.2026.09.003
Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor Therapies
Dannehl, D., Tauber, N., Schäffler, H., Heublein, S., Lichtblau, J., Wisniewski, L., Rack, B., Janni, W., Englisch, A., Englisch, J. F., et al. (2026) · Senologie - Zeitschrift für Mammadiagnostik und -therapie · doi:10.1055/a-2911-1826
Yu, Y. J., Zhu, L. H., & Guo, W. C. (2026) · International Journal of Radiation Research · doi:10.66224/ijrr.24.3.37
Topotecan/quercetin-loaded dextran/poloxamer in-situ implant for breast cancer management
Rout, S. R., Sahoo, R. K., Halder, J., Rai, V. K., Mohapatra, S., Das, A., Manoharadas, S., Al‐Tamimi, J., Goyal, A. K., Kar, B., et al. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108974
Sdinami, S., Maialetti, M., Sebri, V., Zagami, P., Grasso, R., Curigliano, G., & Pravettoni, G. (2026) · Psycho-Oncology · doi:10.1002/pon.70622
Gupta, G., Trivedi, T., Gupta, S., Pipal, D. K., GUPTA, R., Singh, M., Rath, R. S., Prithviraj, M., Yadav, H. K., Rajnish, K., et al. (2026) · Cureus · doi:10.7759/cureus.117585
Metadata
- Authors
- Nardin, S., Mora, E., Varughese, F. M., D'Avanzo, F., Vachanaram, A. R., Rossi, V., Saggia, C., Rubinelli, S., & Gennari, A.
- Affiliations
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Azienda Ospedaliero Universitaria Maggiore della Carita (IT)
- Corresponding author
- Gennari, Alessandra
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-16
- Volume
- 10
- Pages
- 864-864
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC7308500
- OpenAlex
- W3036457113
- Cited by
- 330
- References
- 39
- Citations by year
- 2026: 47 · 2025: 85 · 2024: 83 · 2023: 55 · 2022: 37 · 2021: 21 · 2020: 2
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- breast cancer survivorship, quality of life, late toxicity, breast cancer screening, breast cancer subtypes, targeted therapy, personalized treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
